Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

268 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT03500549

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • Denver Health Denver, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 53 locations
View Trial Details
Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

NCT04463056

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +20 more
Locations
  • Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
  • Moscow State Budget Funded Healthcare Institution S. P. Botkin City Clinical Hospital, Moscow Department of Healthcare Moscow, Russia
  • State Budget Funded Institution of Higher Education Academician I. P. Pavlov Saint-Petersburg State Medical University of the Ministry of Health of the Russian Federation Saint Petersburg, Russia
  • State Budgetary Educational Institution of Higher Professional Education Samara State Medical University, Ministry of Health of the Russian Federation. Samara, Russia
View Trial Details
Completed

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT01807091

Conditions
Adult Acute Myeloid Leukemia, Adult Myelodysplastic Syndrome, Anemia, +11 more
Locations
  • Bozeman Deaconess Hospital Bozeman, Montana, United States
  • Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States
  • EvergreenHealth Medical Center Kirkland, Washington, United States
  • Skagit Valley Hospital Mount Vernon, Washington, United States
View Trial Details
Completed

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

NCT02264639

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +18 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • University of Lousiville Louisville, Kentucky, United States
  • John Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

NCT04679103

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +9 more
Locations
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Chelyabinsk Oblast, Russia
  • Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency" Kirov, Kirov Oblast, Russia
  • Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I.P. Pavlov" Saint Petersburg, Leningradskaya Oblast', Russia
  • Federal State Budgetary Institution "National Medical Research Center of Hematology" of the Ministry of Health of the Russian Federation Moscow, Moscow Oblast, Russia
View Trial Details

Related conditions